Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
359 Newark Pompton Turnpike , Wayne, NJ, 07470, US
New facet to Contract Packager’s growing Cold Storage capabilities helps expand service offerings into biopharma sector
Released By Reed-Lane
David Manis, our Marketing and Sales Associate, was interviewed by Contract Pharma magazine where he discussed the current trends in the Pharmaceutical Packaging industry. He also discussed recent installations at Reed-Lane including serialization, cold chain storage, and our new secondary kitting suite for vials and ampules. CLICK OR DOWNLOAD HERE TO LEARN MORE
Reed-Lane originated over 60 years ago as a supplier of strip packaging. In that tradition, today we have the most advanced high-speed pouching machine in the contract packaging market. Quality You Can Count On Our pouching expertise exemplifies our company-wide blend of longstanding tradition and state-of-the-art innovation: Reed-Lane has a 60-year history with the process, […]
Reed-Lane is a full-service contract packager capable of taking your products straight through the final packaging process. We offer a variety of secondary packaging capabilities, featuring final quality inspections serving as your products’ last stop before entering the market. Full Service Serialization Each of Reed-Lane’s secondary packaging options can incorporate serialization from the unit level […]
As domestic and international track and trace mandates take effect, serialization continues to be among the pharmaceutical industries’ most talked-about topics. Reed-Lane is in full compliance with the FDA’s DSCSA Serialization Track and Trace mandate for prescription medication which went into effect in November 2017. Our serialization partners are Optel Group and TraceLink. Variety of […]
Secure cold storage Our cold storage unit utilizes 100% redundant refrigeration system maintaining the temperature from 2°-8°C. The unit is monitored 24/7, is equipped with an alarm system, and connected to a backup power generator. Reducing excursion time Located next to the refrigeration unit is a dedicated climate controlled secondary packaging suite. The […]
Whether creating customized convenience vials with extended text labeling or unique card sealing designs that enhance retailer shelf space, Reed-Lane’s team of experienced engineers stand ready to design product-specific packaging solutions that best suit our customers’ needs. From Design To Deployment Our process is turnkey from concept to creation. Upon designing your ideal packaging solution, […]
Reed-Lane’s convenience vials packaging produces small or travel-size packages sometimes referred to as Purse Pack Vials. Convenience vials are also a viable option for the sampling of Rx products. Fast Solutions Our turnkey services in this area include sourcing key materials such as vials, child-resistant caps, and various-sized wrap labels for extended content labeling. Multiple […]
As medication regimens become increasingly specific – requiring strict, even down-to-the-hour adherence – the importance of compliance packaging continues to grow. A package that both stresses and fosters proper medication compliance can matter greatly in terms of drug efficacy and, in turn, patient health. Multiple Packaging Options Reed-Lane supplies several compliance packaging options, including a […]
At Reed-Lane, we offer secondary packaging services for biotech customers to include labeling, printing and cartoning of vials and ampules. In addition, we can also provide kitting and hand assembly for biotech customers who need a packaging partner that can fulfill all these crucial secondary packaging steps. Throughout the process we are inspecting and checking […]
Reed-Lane’s bottling lines are capable of packaging solid dose products such as tablets, capsules, caplets, soft gels, liquid gels and gel caps. Bottling Capabilities Our bottling lines utilize slat or electronic filling systems for solid dose products such as tablets, capsules, caplets, soft gels, liquid gels or gel cap forms. These lines are capable of […]
Reed-Lane’s blister lines are capable of running thermoform (PVC, PVDC, Aclar) and cold form (Alu-Alu) blisters. Quality Guaranteed Our blistering operation is both flexible and nimble, allowing us to either work within existing package platforms or collaborate with customers and suppliers to design custom, product-specific tooling or packaging features. Creative Collaboration Our blistering equipment includes […]
With the opening of its first controlled cold storage at its Wayne, NJ packaging facility
Contract packager opens controlled cold storage facility in New Jersey.
On Wednesday, July 18, 2018, the FDA arrived to conduct their bi-annual general audit. After spending a week reviewing our SOPs, training records, quality procedures, and much more the audit concluded. Reed-Lane is proud to announce that we did not receive any 483s! We are proud to continue our longstanding commitment to quality assurance, which is evident […]
A Reed-Lane Challenge
A Reed- Lane Challenge
Contract packager stayed operational, on track and productive throughout
Pharmaceutical contract packager Reed-Lane works with consulting firm, machinery vendors on three key packaging lines to meet fast-approaching serialization enforcement deadline.
Reed-Lane, a New Jersey-based contract packaging provider serving leading pharmaceutical manufacturers, has experienced an uptick in interest in its blister packaging services. The spike in inquiries has followed the company’s double-digit blister packaging capacity growth, spurred by its recent purchase of an additional UPS 4 Blister Machine from Uhlmann Packaging Systems.
New machine accurately applies topserts to solid-dose pharmaceutical bottles.
Expanding the Company’s Overall Packaging Capacity and Capabilities, New Installation is Configured for Larger Fill Levels with Smaller Volumes WAYNE, NJ – Reed-Lane, a New Jersey-based contract packaging provider that serves leading pharmaceutical manufacturers, has installed its sixth bottling line for solid dose RX and OTC products. The new installation serves to expand the […]
New Space Features Optel Vision TrackSafe™ System; Validation to be Completed by Q1 2015
Company Now Has 30% More Warehouse Capacity and Ability to Handle over 100 Million Bottles Per Year
For Reed-Lane, First Launch on Enhanced Uhlmann Packaging Systems UPS4 Blister Line; Company to Add Another UPS4 This Spring
Growth and Flexibility Make Reed-Lane a Valuable Packaging Partner
Contract Packaging for the Healthcare Market: Big Challenges, Big Rewards
Serialization and robotics integration gains momentum
Industry Veteran Brings Compliance Packaging Experience to National Organization Promoting Role of Packaging in Medication Adherence
Why pharma needs automated AI security now.
By: Frank Balonis
Welcomes Brian Riley as President and Chief Technical Officer, Joanne Lager, MD as Chief Medical Officer, and Adrian Chaisson as Chief of Staff.
By: Charlie Sternberg
Dr. Abdul Mutlib is appointed the President of Frontage Laboratories, Canada, and will spearhead growth as he continues to serve as Chief Scientific & Strategy Officer.
By: Rachel Klemovitch
Strengthens BioMarin's enzyme therapies portfolio, adding a late-stage enzyme replacement therapy, INZ-701.
Forms a rare tumor business for Merck KGaA, Darmstadt, Germany, including SpringWorks’ portfolio and pimicotinib.
The U.S. launch of Conexxence and Bomyntra follows the FDA’s approval in March 2025.
Richard Thakor and Daniel Anderson will speak at the event in November.
Strengthens its global particle engineering capabilities.
Will manufacture SurVaxM, a novel immunotherapeutic vaccine designed to treat glioblastoma, for use in clinical trials.
Integrate Keystone’s Key-Pak child-resistant blister cards with Med-Con’s medication adherence prompting and monitoring application.
The company is investing $90 million to expand two U.S. facilities to enhance capacity and efficiency.
Villain offers extensive expertise in peptide and oligonucleotide development and manufacturing.
Collaboration aims to discover and develop novel therapeutics for cardiovascular disease using Novartis’ ProFoundry Platform.
It is the only ready-to-use liquid immunoglobulin therapy with (IgA) content and is set for commercialization in 2026.
The companies have released the first batch of Novalgen’s next-generation T-cell engager for first in-human clinical trials.
The collaboration now is progressing to the in vivo preclinical stage.
Will further expand its domestic capabilities to develop, produce and deliver medicines.
EVP & COO Todd Nelson reflects on Porton J-STAR's defining milestones, global network strategy, and what’s ahead as the company enters its third decade.
Released By Porton
The clinical site is expected to be completed and ready for media fill by the end of 2029.
The company’s label updates are for its CAR T cell therapies, Breyanzi and Abecma.
Is purpose-built for manufacturing high-quality plasmid DNA and viral vectors.
Partnership expected to improve yield and upgrade analytical methods ahead of clinical use and regulatory submissions.
Hervé Hoppenot will retire after 11 years of leading the company through major expansion.
Will commence cell therapy process development and clinical manufacturing services at AGC Inc.’s Yokohama Technical Center.
Agreement to support future studies investigating the combination of ateganosine and atezolizumab for safe and effective cancer treatments.
Will develop and commercialize a potential treatment for obesity and metabolic disease based on technology licensed from the U.S. Department of Veterans Affairs.
Addressing increasing complexity, cost of drug development, and navigating regulatory compliance.
By: Kristin Brooks
Will add further sterile fill/finish capacity over the course of the next year.
Agnus joins Bora Group from KBI Biopharma, where he led global business development.
ST16 Semi-Automated Aggregation Station combines software and flexible hardware to help optimize productivity, improve operational efficiency and streamline processes.
J.D. Mowery brings nearly 25 years of experience in the CDMO and biopharmaceutical industries.
Will combine their biomanufacturing facilities to create a global service for biologics development and supply.
The newly acquired facility provides drug product manufacturing services for sterile injectables.
This strategic partnership provides end-to-end visibility and best-in-class track and trace for Praxis’s customer base.
This integrated solution follows the company’s acquisition of Pharmacontrol Electronic and combines technologies.
This acquisition enhances Systech’s product offerings and enables it to offer a more comprehensive product portfolio to its customers.
Offers quick compliance, avoids delays, and optimizes production with multi-scan and mobile flexibility.
CEO Owen Murray on driving innovation with high science and high service.
By: Tim Wright
Mark DaFonseca is a seasoned CDMO and pharmaceutical services executive with nearly 30 years of pharmaceutical industry experience.
What’s at stake in the face of enforcement deadlines and how exception management lays the groundwork for future-ready supply chains.
By: Tracy Nasarenko
Will leverage AbbVie's expertise in biotherapeutic drug development and commercialization with ADARx's proprietary RNA technology.
How Praxis Packaging delivers flexible, reliable solutions for pharmaceutical contract packaging needs.
Released By Praxis Packaging Solutions
Atzumi is a DHE nasal powder for acute treatment of migraine in adults.
Xavier Jacq is a scientist with extensive experience in small molecule drug development and mitochondrial biology.
Regulus’ lead asset, farabursen, is a potential first-in-class, next-gen oligonucleotide targeting miR-17 for the treatment of ADPKD.
Adds Dordaviprone to its oncology portfolio and advances its efforts to address unmet patient needs.
The company also establishes an office in the San Francisco Bay Area.
The acquisition expands Siemens’ Digital Twin technology and AI-powered software into the rapidly growing Life Sciences market.
Becomes well-positioned as a CDMO for advanced therapy developers looking for end-to-end capabilities.
Novartis cuts approximately 430 employees from East Hanover HQ, and 34 employees in San Diego.
Blujepa’s approval is based on positive results from the pivotal phase III EAGLE-2 and EAGLE-3 trials.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
